Related Experiment Video

Updated: Aug 11, 2026

Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
05:18

Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome

Published on: May 26, 2023

Corticosteroids in polymyalgia rheumatica--a review of different treatment schedules

C Li1, B Dasgupta

  • 1Department of Rheumatology, Southend Hospital, Westcliff-on-Sea, Essex, UK. dr.dasgupta@southend-hospital.thenhs.com

Clinical and Experimental Rheumatology
|August 19, 2000
PubMed

Insights

Low dose oral steroids are standard for polymyalgia rheumatica (PMR), but intramuscular methylprednisolone offers similar efficacy with fewer side effects. Osteoporosis prophylaxis with calcium and vitamin D is crucial during steroid treatment.

Area of Science:

  • Rheumatology
  • Pharmacology
  • Endocrinology

Background:

  • Low-dose oral steroids (prednisolone 10-15 mg daily) are the current standard for uncomplicated polymyalgia rheumatica (PMR).
  • Steroid dosage requires careful adjustment based on disease activity.
  • Osteoporosis is a significant concern in patients receiving long-term steroid therapy.

Purpose of the Study:

  • To compare the efficacy and side effect profiles of oral steroids versus intramuscular methylprednisolone for PMR treatment.
  • To emphasize the importance of osteoporosis prophylaxis in patients undergoing steroid therapy for PMR.

Main Methods:

  • Review of existing literature comparing oral prednisolone and intramuscular methylprednisolone in PMR management.
  • Analysis of data regarding remission rates, fracture incidence, and weight gain.
  • Assessment of recommendations for osteoporosis prophylaxis.

Main Results:

  • Intramuscular methylprednisolone demonstrates comparable remission rates to oral steroids in uncomplicated PMR.
  • Intramuscular methylprednisolone exhibits a more favorable side effect profile, specifically lower rates of fracture and weight gain.
  • Prophylaxis for osteoporosis, including calcium and vitamin D, is recommended at the initiation of steroid therapy.

Conclusions:

  • Intramuscular methylprednisolone presents a viable alternative to oral steroids for PMR treatment, potentially offering improved safety.
  • Early initiation of osteoporosis prophylaxis is essential for all patients starting steroid therapy for PMR to mitigate long-term bone health risks.

More Related Videos

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

Related Concept Videos

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...